13 Feb 2023 • In a significant multinational trial, it was found that performing endovascular thrombectomy in patients with an ischemic stroke with a significant ischemic core was advantageous. In patients with a big ischemic core who presented within 24 hours of the time they were last known to be healthy, the endovascular thrombectomy plus medical care produced better clinical outcomes than medical care alone, according to the findings of the SELECT2 trial, which was carried out in sites in the United States, Canada, Europe, Australia, and New Zealand. The trial's primary insight was that thrombectomy had a generalised odds ratio of 1.51 (P .001) for a shift in the distribution of modified Rankin scale scores towards better outcomes. This translates into a 60% chance for patients who receive thrombectomy to have a better functional outcome. In the thrombectomy group, 20% of patients experienced functional independence at 90 days, compared to 7% of patients in the medical-care group. At 90 days, 18.7% of patients in the medical-care group and 37.9% of patients who underwent thrombectomy experienced independent ambulation.  Dr. Tudor Jovin, New Jersey's Cooper Neurological Institute said: "This study indicates that thrombectomy is effective even in patients with a large core infarct, who we would not have previously treated with it. The effect is nearly as great as in patients with smaller core infarcts, which is a surprise. That is going to change practice."

Source: Medscape | Read full story